Evolution of Solid Dispersion Technology: Solubility Enhancement Using Hydroxypropyl Methylcellulose Acetate Succinate: Myth or Reality?

被引:5
作者
Babu, N. Raveendra [1 ,2 ]
Nagpal, Dheeraj [2 ]
Ankola, Dhawal [1 ]
Awasthi, Rajendra [3 ,4 ]
机构
[1] Watson Pharm Pvt Ltd, Teva Co, Thana, India
[2] Amity Univ Uttar Pradesh, Amity Inst Pharm, Dev Pharmaceut, Noida, India
[3] Univ Petr & Energy Studies UPES, Sch Hlth Sci & Technol, Dept Pharmaceut Sci, Dehra Dun, India
[4] Univ Petr & Energy Studies UPES, Sch Hlth Sci & Technol, Dept Pharmaceut Sci, Energy Acres, Bidholi,Via-Prem Nagar, Dehra Dun 248 007, Uttaranchal, India
关键词
dissolution; polymorph; polymer; solid dispersion; solubility; ENTERIC COATING AGENT; ORAL BIOAVAILABILITY; DISSOLUTION RATES; DRUG AVAILABILITY; EUTECTIC MIXTURE; PARTICLE-SIZE; ABSORPTION; POLYMERS; DESIGN; POLYVINYLPYRROLIDONE;
D O I
10.1089/adt.2022.016
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Poorly aqueous soluble active pharmaceutical ingredients are highly risky development candidates and remain a concern of pharmaceutical industries in drug discovery and development processes. Pharmaceutical industries are putting significant efforts into the target identification and lead candidate development using combinatorial chemistry. About 40% of compounds arising from combinatorial screening are poorly water soluble. Pharmaceutical industries evolved over this challenge by coming up with reproducible and scalable particle size reduction or by identifying alternate morphs. Another important area where pharmaceutical industries are working is solid dispersion technology. With the emergence of the hot-melt extrusion and spray drying approach, many molecules have been brought to the market using solid dispersion technology from the discovery phase by improving bioavailability and thereby efficacy. Although the solid solution technology in the last 60 years evolved from eutectic mixtures, solid dispersions using water-soluble polymers, and enteric polymers especially hydroxypropyl methylcellulose acetate succinate (HPMCAS), still there is no preformulation tool to identify correct polymer or polymer combination at the early stage of development. Thus, this leads to the urgent need to focus on the design and development of third-generation solid dispersions for the unmet needs of the industries and society.
引用
收藏
页码:149 / 163
页数:15
相关论文
共 62 条
[1]  
[Anonymous], ENZALUTAMIDE CAPSULE
[2]  
[Anonymous], CHMP ASSESSMENT REPO
[3]  
[Anonymous], PROCEDURE EMEA H C 0
[4]   EFFECT OF PARTICLE SIZE ON BLOOD GRISEOFULVIN-LEVELS IN MAN [J].
ATKINSON, RM ;
TOMICH, EG ;
BEDFORD, C ;
CHILD, KJ .
NATURE, 1962, 193 (4815) :588-&
[5]  
Bittorf KJ., 2012, US Patent, Patent No. [20120083441A1, 20120083441]
[6]   Vemurafenib: the first drug approved for BRAF-mutant cancer [J].
Bollag, Gideon ;
Tsai, James ;
Zhang, Jiazhong ;
Zhang, Chao ;
Ibrahim, Prabha ;
Nolop, Keith ;
Hirth, Peter .
NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (11) :873-886
[7]   In Vivo Dog Intestinal Precipitation of Mebendazole: A Basic BCS Class II Drug [J].
Carlert, Sara ;
Akesson, Pernilla ;
Jerndal, Gunilla ;
Lindfors, Lennart ;
Lennernas, Hans ;
Abrahamsson, Bertil .
MOLECULAR PHARMACEUTICS, 2012, 9 (10) :2903-2911
[8]   PREPARATION AND DISSOLUTION CHARACTERISTICS OF SEVERAL FAST-RELEASE SOLID DISPERSIONS OF GRISEOFULVIN [J].
CHIOU, WL ;
RIEGELMAN, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1969, 58 (12) :1505-+
[9]   ABSORPTION CHARACTERISTICS OF SOLID DISPERSED AND MICRONIZED GRISEOFULVIN IN MAN [J].
CHIOU, WL ;
RIEGELMAN, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (09) :1376-+
[10]  
CHMP assessment report for Intelence, CHMP ASSESSMENT REPO